Groundbreaking Trial at the Mayo Clinic
In a ground-breaking trial for researchers and physicians at the Mayo Clinic, stem cells will be put to use in their first clinical trial on patients with a rare early-childhood heart disease. Hypoplastic left heart syndrome (HLHS) is a defect characterized...(read more)
Source: ADVANCE Discourse: Lab - Category: Pathologists Authors: Michael Jones Tags: Current Events Molecular Diagnostics Pathology Research Source Type: blogs
More News: Cardiology | Clinical Trials | Heart | Heart Disease | Pathologists | Pathology | Stem Cell Therapy | Stem Cells